Michael G. Erickson - Feb 13, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael G. Erickson
Stock symbol
IDXX
Transactions as of
Feb 13, 2025
Transactions value $
-$78,682
Form type
4
Date filed
2/18/2025, 09:42 PM
Previous filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +69 +0.33% $0.00 20.9K Feb 14, 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +93 +0.44% $0.00 21K Feb 14, 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +94 +0.45% $0.00 21.1K Feb 14, 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +301 +1.43% $0.00 21.4K Feb 14, 2025 Direct
transaction IDXX Common Stock Tax liability -$78.7K -177 -0.83% $444.53 21.2K Feb 14, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +6.32K $0.00 6.32K Feb 13, 2025 Common Stock 6.32K $459.76 Direct F1
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.00 217 Feb 13, 2025 Common Stock 217 $459.76 Direct F2
transaction IDXX Restricted Stock Unit Award $0 +734 $0.00 734 Feb 13, 2025 Common Stock 734 Direct F3
transaction IDXX Restricted Stock Unit Award $0 +734 $0.00 734 Feb 13, 2025 Common Stock 734 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -69 -100% $0.00 0 Feb 14, 2025 Common Stock 69 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -93 -50.27% $0.00 92 Feb 14, 2025 Common Stock 93 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -94 -33.33% $0.00 188 Feb 14, 2025 Common Stock 94 Direct F7
transaction IDXX Restricted Stock Unit Options Exercise $0 -301 -25% $0.00 903 Feb 14, 2025 Common Stock 301 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F3 Grant of restricted stock units ('RSU') that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2022.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2024.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments, beginning on February 14, 2025.